Skip to main content
Premium Trial:

Request an Annual Quote

Nasdaq Notifies Great Basin of Listing Non-Compliance

NEW YORK (GenomeWeb) – The Nasdaq Listings Qualifications Staff has notified Great Basin Scientific that it fails to meet requirements to continue listing its shares on the exchange, the company said after the close of the market on Tuesday. 

Salt Lake City-based Great Basin said that the Nasdaq notified it on Oct. 14 that it failed to meet listing requirements calling for a minimum $35 million market value of listed securities and a $1 minimum bid price on its shares. The firm has a current market value of about $17 million. Its shares closed on Tuesday down about 4 percent at $.09 per share.   

Nasdaq has given the molecular diagnostics firm 180 calendar days, or through April 11, to regain compliance. If Great Basin fails to meet the requirements by the deadline, it can receive another 180-day grace period provided it meets certain conditions. 

The firm said that it is considering its options to address the deficiencies, including a previously announced plan to file a proxy statement and hold a special shareholders meeting to seek approval to effect a reverse stock split. 

Great Basin went public a year ago. 

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.